You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Brief News on Innovation
Company News Brief News on Innovation
Brief News on Innovation
TaurusNXT® NON-GLUTARALDEHYDE CROSSLINKED DRY-TISSUE TAVR SYSTEM COMPLETED ALL PATIENT ENROLLMENT OF ITS PIVOTAL CLINICAL TRIAL
2024.03.01
TaurusNXT® NON-GLUTARALDEHYDE CROSSLINKED DRY-TISSUE TAVR SYSTEM COMPLETED ···

In February 2024, TaurusNXT® Non-glutaraldehyde Crosslinked dry-tissue TAVR syst···
TaurusAtlas Pro, THE SECOND-GENERATION BALLOON DILATATION CATHETER, HAS BEEN APPROVED BY THE NMPA
2024.02.01
TaurusAtlas Pro, THE SECOND-GENERATION BALLOON DILATATION CATHETER, HAS BEE···

The registration application of TaurusAtlas Pro, the second-generation balloon d···
TaurusTrio AR TAVR SYSTEM COMPLETED ALL PATIENT ENROLLMENT OF ITS MULTI-CENTER PIVOTAL CLINICAL TRIAL
2024.01.29
TaurusTrio AR TAVR SYSTEM COMPLETED ALL PATIENT ENROLLMENT OF ITS MULTI-CEN···

In January 2024, TaurusTrio AR TAVR System  successfully completed patient ···
Academic Conferences at Home and Abroad are in Full Swing, Where Peijia Medical Has  Showcased a Variety of Products and Received Enthusiastic Responses
2023.12.29
Academic Conferences at Home and Abroad are in Full Swing, Where Peijia Med···

❖ TaurusOne® Transcatheter Aortic Valve Replacement (TAVR) System■ Four-Year Cli···
Shanghai Renji Hospital Completed the First Patient Enrollment of the Registration Clinical  Trial of Achieva’s CereStellar™ Intracranial Assist Stent
2023.12.22
Shanghai Renji Hospital Completed the First Patient Enrollment of the Regis···

Achieva Medical initiated a prospective, multi-center, randomized-controlled cli···
Prof. Yu Bo's Team at the Second Affiliated Hospital of Harbin Medical University  Successfully Completed the First Enrollment at the Chinese Clinical Trial Center for Peijia  HighLife® Trans-septal Mitral Valve Replacement (TSMVR) System
2023.11.01
Prof. Yu Bo's Team at the Second Affiliated Hospital of Harbin Medical Univ···

On October 31, 2023, the team led by Prof. Yu Bo at the Second Affiliated Hospit···
Professor Song Guangyuan and His Team at Beijing Anzhen Hospital have Successfully  Completed the First Day Enrollment in the Multi-Center Registration Clinical Trial of  TaurusTrio™
2023.07.31
Professor Song Guangyuan and His Team at Beijing Anzhen Hospital have Succe···

On July 26, 2023, Professor Song Guangyuan, the Director of the Heart Valve Inte···
NMPA APPROVAL FOR REGISTRATION APPLICATION OF DCwire™ MICRO GUIDEWIRE
2023.07.07
NMPA APPROVAL FOR REGISTRATION APPLICATION OF DCwire™ MICRO GUIDEWIRE

This announcement is made by Peijia Medical Limited (the “Company”, together wit···
First Asian Commercial Implants with the Trilogy Heart Valve System performed by Dr. Michael Lee and His Team in Queen Elizabeth Hospital in Hong Kong
2023.05.18
First Asian Commercial Implants with the Trilogy Heart Valve System perform···

On May 12th, 2023, Dr. Michael Lee and his team from the Cardiology Department o···
FIRST PATIENT ENROLLMENT IN THE MULTI-CENTER REGISTRATION CLINICAL TRIAL OF GeminiOne® TRANSCATHETER EDGE-TO-EDGE REPAIR SYSTEM IN CHINA
2022.12.04
FIRST PATIENT ENROLLMENT IN THE MULTI-CENTER REGISTRATION CLINICAL TRIAL OF···

FIRST PATIENT ENROLLMENT IN THE MULTI-CENTER REGISTRATION CLINICAL TRIAL OF Gem···
FIRST PATIENT IMPLANT IN THE FIRST-IN-MAN CLINICAL TRIAL OF THE MonarQ TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM IN THE WORLD
2022.11.25
FIRST PATIENT IMPLANT IN THE FIRST-IN-MAN CLINICAL TRIAL OF THE MonarQ TRAN···

FIRST PATIENT IMPLANT IN THE FIRST-IN-MAN CLINICAL TRIAL OF THE MonarQ TRANSCAT···
FIRST PATIENT IMPLANT IN MULTI-CENTER REGISTRATION CLINICAL TRIAL OF PEIJIA HighLife® TRANSCATHETER MITRAL VALVE REPLACEMENT SYSTEM IN CHINA
2022.11.14
FIRST PATIENT IMPLANT IN MULTI-CENTER REGISTRATION CLINICAL TRIAL OF PEIJIA···

FIRST PATIENT IMPLANT IN MULTI-CENTER REGISTRATION CLINICAL TRIAL OF PEIJIA Hig···
Home < ···23456 > Last
Top